Все публикации

0:19:07

Developing Your Immuno-Oncology Molecule

1:04:30

Chronic Pain: Conducting Clinical Trials in Osteoarthritis

0:48:50

The Role of Clinical Endpoint Committees in Medical Device Trials

0:51:41

Expanding the Potential of Immuno-Oncology Therapies

0:03:41

Remember, We're Dealing With Real People

0:02:47

How Do You Actually Go About Engaging?

0:02:51

What Does Patient-Centricity Mean to You?

1:00:21

Natural History vs. Registry Studies in Rare Disease: Which, When, and How?

0:03:10

Patient Populations and Biomarkers

0:04:41

Phase I - II Considerations

0:03:14

The Regulatory Environment

0:02:17

Maximizing the Molecules

1:09:07

From Laboratory to Bedside: Expediting Development of Novel Rare Cancer Treatments

0:57:15

Medical Device Regulation: Finding Your Path to Success

0:06:51

Orphan Drug Congress Nov 2013: Part 3, How to Help Inexperienced Sites Conduct Successful Studies

0:09:31

Orphan Drug Congress Nov 2013: Part 4, Role of Advocacy Groups Networks & Compassionate Use Pro

0:20:29

Orphan Drug Congress April 2013: Part 1, Approaches to Clinical Trial Design

0:07:38

Orphan Drug Congress Nov 2013: Part 2, How to Successfully Engage Regulators

0:03:35

Orphan Drug Congress April 2013: Part 4, Logistics and Costs

0:10:17

Orphan Drug Congress Nov 2013: Part 1, Study Design Considerations

0:10:28

Orphan Drug Congress April 2013: Part 3, Trial Implementation

0:08:00

Orphan Drug Congress April 2013: Part 2, Regulatory Landscape

0:01:23

What can we do to increase the number of new biomarkers?

0:02:17

How do you meet the challenge of developing molecules quickly?